NCT02171221View on ClinicalTrials.gov

Phase I Study of Oral DFP-11207 in Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 13, 2018

Study Completion Date

September 13, 2018

Conditions
Solid TumorsCancer
Interventions
DRUG

Oral DFP-11207

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Delta-Fly Pharma, Inc.

INDUSTRY